MAP
Moody Aldrich Partners’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.43M | Buy |
170,570
+7,087
| +4% | +$392K | 1.82% | 2 |
|
|
2025
Q1 | $7.91M | Buy |
163,483
+96,068
| +143% | +$4.65M | 1.66% | 12 |
|
|
2024
Q4 | $2.6M | Sell |
67,415
-51,872
| -43% | -$2M | 0.48% | 81 |
|
|
2024
Q3 | $5.37M | Sell |
119,287
-14,928
| -11% | -$672K | 0.98% | 41 |
|
|
2024
Q2 | $4.65M | Buy |
134,215
+33,696
| +34% | +$1.17M | 0.91% | 47 |
|
|
2024
Q1 | $2.91M | Buy |
100,519
+38,192
| +61% | +$1.1M | 0.49% | 81 |
|
|
2023
Q4 | $1.43M | Sell |
62,327
-6,641
| -10% | -$152K | 0.26% | 109 |
|
|
2023
Q3 | $1.15M | Buy |
68,968
+27,108
| +65% | +$452K | 0.22% | 113 |
|
|
2023
Q2 | $1.16M | Buy |
+41,860
| New | +$1.16M | 0.22% | 114 |
|